Immunome Stock Price History
IMNM Stock | USD 9.99 0.13 1.32% |
If you're considering investing in Immunome Stock, it is important to understand the factors that can impact its price. As of today, the current price of Immunome stands at 9.99, as last reported on the 21st of January, with the highest price reaching 10.39 and the lowest price hitting 9.69 during the day. Immunome holds Efficiency (Sharpe) Ratio of -0.0245, which attests that the entity had a -0.0245 % return per unit of risk over the last 3 months. Immunome exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Immunome's Market Risk Adjusted Performance of (0.15), risk adjusted performance of (0.01), and Standard Deviation of 5.0 to validate the risk estimate we provide.
Immunome Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Immunome |
Sharpe Ratio = -0.0245
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | IMNM |
Estimated Market Risk
5.08 actual daily | 45 55% of assets are more volatile |
Expected Return
-0.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Immunome is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immunome by adding Immunome to a well-diversified portfolio.
Immunome Stock Price History Chart
There are several ways to analyze Immunome Stock price data. The simplest method is using a basic Immunome candlestick price chart, which shows Immunome price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | December 9, 2024 | 14.53 |
Lowest Price | November 20, 2024 | 9.33 |
Immunome January 21, 2025 Stock Price Synopsis
Various analyses of Immunome's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Immunome Stock. It can be used to describe the percentage change in the price of Immunome from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Immunome Stock.Immunome Price Action Indicator | 0.02 | |
Immunome Price Daily Balance Of Power | 0.19 | |
Immunome Price Rate Of Daily Change | 1.01 |
Immunome January 21, 2025 Stock Price Analysis
Immunome Stock Price History Data
The price series of Immunome for the period between Wed, Oct 23, 2024 and Tue, Jan 21, 2025 has a statistical range of 5.2 with a coefficient of variation of 12.15. Under current investment horizon, the daily prices are spread out with arithmetic mean of 11.63. The median price for the last 90 days is 11.53.Open | High | Low | Close | Volume | ||
01/21/2025 | 10.02 | 10.39 | 9.69 | 9.99 | ||
01/17/2025 | 10.02 | 10.39 | 9.69 | 9.99 | 900,330 | |
01/16/2025 | 10.63 | 11.06 | 9.60 | 9.86 | 1,313,542 | |
01/15/2025 | 9.81 | 10.15 | 9.50 | 10.11 | 670,321 | |
01/14/2025 | 10.12 | 10.13 | 9.24 | 9.38 | 517,590 | |
01/13/2025 | 10.35 | 10.49 | 9.36 | 10.04 | 1,036,384 | |
01/10/2025 | 10.37 | 10.66 | 10.27 | 10.60 | 865,085 | |
01/08/2025 | 10.72 | 10.85 | 10.35 | 10.66 | 334,889 | |
01/07/2025 | 11.40 | 11.60 | 10.71 | 10.76 | 371,654 | |
01/06/2025 | 11.46 | 11.56 | 11.03 | 11.20 | 568,465 | |
01/03/2025 | 10.61 | 11.36 | 10.61 | 11.27 | 705,199 | |
01/02/2025 | 10.72 | 11.16 | 10.47 | 10.53 | 579,297 | |
12/31/2024 | 10.43 | 10.74 | 10.20 | 10.62 | 1,036,301 | |
12/30/2024 | 10.42 | 10.57 | 10.11 | 10.28 | 464,305 | |
12/27/2024 | 11.00 | 11.16 | 10.37 | 10.54 | 2,457,083 | |
12/26/2024 | 11.00 | 11.28 | 10.84 | 11.10 | 377,611 | |
12/24/2024 | 10.98 | 11.08 | 10.67 | 11.02 | 594,254 | |
12/23/2024 | 10.97 | 11.08 | 10.75 | 10.97 | 1,281,110 | |
12/20/2024 | 10.94 | 11.50 | 10.82 | 10.97 | 1,453,565 | |
12/19/2024 | 11.26 | 11.44 | 10.86 | 11.08 | 1,029,555 | |
12/18/2024 | 12.01 | 12.14 | 10.76 | 11.11 | 1,076,071 | |
12/17/2024 | 12.40 | 12.54 | 11.70 | 12.02 | 894,575 | |
12/16/2024 | 12.55 | 12.85 | 12.23 | 12.44 | 548,487 | |
12/13/2024 | 13.00 | 13.13 | 12.34 | 12.58 | 595,219 | |
12/12/2024 | 13.47 | 14.09 | 13.00 | 13.07 | 535,087 | |
12/11/2024 | 13.99 | 14.10 | 12.99 | 14.04 | 671,537 | |
12/10/2024 | 14.42 | 14.42 | 13.34 | 13.90 | 699,885 | |
12/09/2024 | 13.90 | 15.13 | 13.90 | 14.53 | 796,219 | |
12/06/2024 | 12.83 | 13.84 | 12.55 | 13.73 | 462,461 | |
12/05/2024 | 13.47 | 13.63 | 12.67 | 12.70 | 661,748 | |
12/04/2024 | 13.65 | 14.09 | 12.96 | 13.54 | 896,480 | |
12/03/2024 | 14.00 | 14.17 | 13.27 | 13.54 | 679,021 | |
12/02/2024 | 13.93 | 14.47 | 13.64 | 14.08 | 972,423 | |
11/29/2024 | 13.44 | 13.66 | 13.08 | 13.55 | 438,919 | |
11/27/2024 | 11.68 | 13.53 | 11.62 | 13.47 | 1,383,648 | |
11/26/2024 | 11.15 | 11.81 | 10.82 | 11.53 | 1,014,855 | |
11/25/2024 | 11.10 | 11.31 | 10.67 | 11.15 | 2,247,455 | |
11/22/2024 | 9.46 | 10.03 | 9.32 | 9.82 | 1,176,158 | |
11/21/2024 | 9.43 | 9.71 | 9.05 | 9.42 | 662,955 | |
11/20/2024 | 9.29 | 9.36 | 8.97 | 9.33 | 700,392 | |
11/19/2024 | 9.28 | 9.53 | 9.19 | 9.39 | 705,339 | |
11/18/2024 | 10.20 | 10.20 | 9.41 | 9.44 | 1,877,386 | |
11/15/2024 | 11.19 | 11.19 | 9.64 | 9.90 | 3,166,549 | |
11/14/2024 | 11.57 | 11.66 | 10.70 | 11.14 | 1,350,565 | |
11/13/2024 | 12.74 | 12.77 | 11.55 | 11.59 | 613,682 | |
11/12/2024 | 12.93 | 13.09 | 12.40 | 12.49 | 519,822 | |
11/11/2024 | 13.22 | 13.52 | 12.70 | 13.26 | 416,500 | |
11/08/2024 | 13.26 | 13.47 | 12.71 | 12.98 | 547,758 | |
11/07/2024 | 13.09 | 13.63 | 12.46 | 12.54 | 632,999 | |
11/06/2024 | 13.45 | 13.66 | 13.02 | 13.10 | 571,382 | |
11/05/2024 | 12.78 | 13.00 | 12.50 | 12.97 | 414,797 | |
11/04/2024 | 11.52 | 12.86 | 11.40 | 12.81 | 672,948 | |
11/01/2024 | 11.81 | 11.92 | 11.48 | 11.59 | 632,575 | |
10/31/2024 | 12.07 | 12.08 | 11.43 | 11.47 | 507,607 | |
10/30/2024 | 12.06 | 12.42 | 11.90 | 12.20 | 261,637 | |
10/29/2024 | 12.47 | 12.47 | 11.93 | 12.20 | 381,013 | |
10/28/2024 | 12.34 | 12.72 | 12.17 | 12.43 | 289,613 | |
10/25/2024 | 12.10 | 12.65 | 11.91 | 12.11 | 501,562 | |
10/24/2024 | 11.73 | 12.06 | 11.64 | 12.01 | 352,171 | |
10/23/2024 | 11.64 | 11.91 | 11.33 | 11.60 | 415,021 | |
10/22/2024 | 11.82 | 11.91 | 11.36 | 11.71 | 789,125 |
About Immunome Stock history
Immunome investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Immunome is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Immunome will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Immunome stock prices may prove useful in developing a viable investing in Immunome
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania. Immunome operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs people.
Immunome Stock Technical Analysis
Immunome technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
All Next | Launch Module |
Immunome Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Immunome's price direction in advance. Along with the technical and fundamental analysis of Immunome Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Immunome to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.01) | |||
Jensen Alpha | (0.16) | |||
Total Risk Alpha | (0.26) | |||
Treynor Ratio | (0.16) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunome. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Immunome Stock, please use our How to Invest in Immunome guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunome. If investors know Immunome will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunome listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Immunome is measured differently than its book value, which is the value of Immunome that is recorded on the company's balance sheet. Investors also form their own opinion of Immunome's value that differs from its market value or its book value, called intrinsic value, which is Immunome's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunome's market value can be influenced by many factors that don't directly affect Immunome's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunome's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunome is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunome's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.